Searchable Patents Journal

Search details
          Search details help

   Results per page

Currently viewing: Intellectual Property Office - Patents Journal : SPCs
From 2017 April 26th - 6675 to 2017 April 26th - 6675
Refine: 

  • Help on this tab
    • Page
    • Previous
    • 1
    • Next
Publication
Date
SPC No.SPC
Category
Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By"
26 April 2017
(Journal 6675)
SPC/GB04/012ExpiredApplicant: Janssen Pharmaceuticals, Inc.
1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States of America

Product: Tramadol Hydrochloride, Paracetamol

Product Type: Medicinal
Authorised: FR NL 25970 5 April 2002
UK PL 00242/0384 25 September 2003

Authorised Extension:

Patent No: EP0566709
Title: Composition comprising a Tramadol Compound and Acetaminophen, and its use

SPC No: SPC/GB04/012
Date Expired: 4 April 2017
26 April 2017
(Journal 6675)
SPC/GB17/025LodgedApplicant: Pharmacyclics LLC
995 East Arques Avenue, Sunnyvale, CA 94085 (US)

Product: Ibrutinib, or a pharmaceutically acceptable salt thereof

Product Type: Medicinal
Authorised: UK EU/1/14/945 7 July 2015
UK C(2015)4704 7 July 2015

Authorised Extension:

Patent No: EP2529621
Title: Inhibitors of bruton's tyrosine kinase

SPC No: SPC/GB17/025
Date Lodged: 28 March 2017
26 April 2017
(Journal 6675)
SPC/GB17/026LodgedApplicant: Warner-Lambert Compnmay LLC
235, East 42nd Street, New York, New York 10017, USA

Product: Palbociclib, optionally in the form of a pharmaceutically acceptable salt, ester, amide or prodrug therof

Product Type: Medicinal
Authorised: UK EU/1/16/1147 9 November 2016

Authorised Extension:

Patent No: EP1470124
Title: 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3D]PYRIMIDIN-7-ONES

SPC No: SPC/GB17/026
Date Lodged: 29 March 2017
26 April 2017
(Journal 6675)
SPC/GB17/027LodgedApplicant: ImClone LLC
450 East 29th Street, 12th Floor, New York, NY, NY0016, United States of America

Product: Olaratumab (lartruvo®)

Product Type: Medicinal
Authorised: UK EU/1/16/1143 11 November 2016

Authorised Extension:

Patent No: EP2100614
Title: Antibody against PDGFR-alpha for use in the treatment of tumours

SPC No: SPC/GB17/027
Date Lodged: 31 March 2017
  • Page 1 of 1 (4 hits)
  • Page
  • Previous
  • 1
  • Next

Tell us about a problem